# L_2023072EN.01002401.xml

| 9.3.2023 | EN | Official Journal of the European Union | L 72/24 |
| --- | --- | --- | --- |

9.3.2023

EN

Official Journal of the European Union

L 72/24

---

DECISION OF THE EEA JOINT COMMITTEE No 60/2020

of 30 April 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/485]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 (1) is to be incorporated into the EEA Agreement.

| (2) | Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 (2) is to be incorporated into the EEA Agreement. |
| --- | --- |

(2)

Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 (2) is to be incorporated into the EEA Agreement.

| (3) | Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 (3) is to be incorporated into the EEA Agreement. |
| --- | --- |

(3)

Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 (3) is to be incorporated into the EEA Agreement.

| (4) | Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 (4) is to be incorporated into the EEA Agreement. |
| --- | --- |

(4)

Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 (4) is to be incorporated into the EEA Agreement.

| (5) | Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (5) is to be incorporated into the EEA Agreement. |
| --- | --- |

(5)

Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (5) is to be incorporated into the EEA Agreement.

| (6) | Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement. |
| --- | --- |

(6)

Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement.

| (7) | Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (7) is to be incorporated into the EEA Agreement. |
| --- | --- |

(7)

Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (7) is to be incorporated into the EEA Agreement.

| (8) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(8)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzc (Commission Implementing Regulation (EU) 2019/1692) of Chapter XV of Annex II to the EEA Agreement:

| ‘12zzzzzzd. | 32019 D 1942: Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 (OJ L 303, 25.11.2019, p. 29). |
| --- | --- |

‘12zzzzzzd.

32019 D 1942: Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 (OJ L 303, 25.11.2019, p. 29).

| 12zzzzzze. | 32019 D 1950: Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 (OJ L 304, 26.11.2019, p. 19). |
| --- | --- |

12zzzzzze.

32019 D 1950: Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 (OJ L 304, 26.11.2019, p. 19).

| 12zzzzzzf. | 32019 D 1951: Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 (OJ L 304, 26.11.2019, p. 21). |
| --- | --- |

12zzzzzzf.

32019 D 1951: Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 (OJ L 304, 26.11.2019, p. 21).

| 12zzzzzzg. | 32019 D 1959: Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 306, 27.11.2019, p. 40). |
| --- | --- |

12zzzzzzg.

32019 D 1959: Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 306, 27.11.2019, p. 40).

| 12zzzzzzh. | 32019 D 1960: Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 306, 27.11.2019, p. 42). |
| --- | --- |

12zzzzzzh.

32019 D 1960: Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 306, 27.11.2019, p. 42).

| 12zzzzzzi. | 32019 D 1969: Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 (OJ L 307, 28.11.2019, p. 45). |
| --- | --- |

12zzzzzzi.

32019 D 1969: Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 (OJ L 307, 28.11.2019, p. 45).

| 12zzzzzzj. | 32019 D 1973: Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 307, 28.11.2019, p. 58).’ |
| --- | --- |

12zzzzzzj.

32019 D 1973: Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (OJ L 307, 28.11.2019, p. 58).’

Article 2

The texts of Implementing Decisions (EU) 2019/1942, (EU) 2019/1950, (EU) 2019/1951, (EU) 2019/1959, (EU) 2019/1960, (EU) 2019/1969 and (EU) 2019/1973 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 1 May 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 30 April 2020.

For the EEA Joint Committee

The President

Clara GANSLANDT

---

(1)  
  OJ L 303, 25.11.2019, p. 29.

1

(2)  
  OJ L 304, 26.11.2019, p. 19.

2

(3)  
  OJ L 304, 26.11.2019, p. 21.

3

(4)  
  OJ L 306, 27.11.2019, p. 40.

4

(5)  
  OJ L 306, 27.11.2019, p. 42.

5

(6)  
  OJ L 307, 28.11.2019, p. 45.

6

(7)  
  OJ L 307, 28.11.2019, p. 58.

7

(*)  No constitutional requirements indicated.

*

---